DR. RICHARD I LEVIN, M.D.
Osteopathic Medicine at 106 St, New York, NY

5724580, Mar 3, 1998

Mar 20, 1997

8/822177

Richard I. Levin - New York NY
Michael W. Cox - Point Pleasant NJ

qmed, Inc. - Lawrence Harbor NJ

G06F 1730

395615

A system and method of automatically formulating an alpha-numeric comprehensive management and prognosis report at a centralized data management center for a patient at a remote location is defined comprising: means for converting information regarding the condition of the patient into data; a first telecommunications means for transferring data to the centralized data management center; and processing means at the centralized data management center for receiving the data and for generating the comprehensive management and prognosis report based on analysis of the data. A storage means is also provided at the centralized data management center for maintaining a record of the data received by and transmitted from the centralized data management center in a relational data base format.

4679144, Jul 7, 1987

Aug 21, 1984

6/642690

Michael W. Cox - Lincroft NJ
Richard I. Levin - New York NY
David J. Cohen - Sag Harbor NY
William R. Frisbie - East Hampton NY

Q-Med, Inc. - Clark NJ

G06F 1542, G06G 760, A61B 504

364417

An apparatus for monitoring EKG information includes a programmable apparatus carried by an ambulatory patient for performing continuous, real-time analyses of EKG information derived from the patient. The apparatus facilitates the determination of the existence of various conditions based on these analyses which portend cardiac complications including myocardial ischemia, and arrhythemia activity and further instructs the patient on the manner of treatment required for the detected condition.

5932558, Aug 3, 1999

Sep 13, 1996

8/712942

Bruce N. Cronstein - New York NY
Richard I. Levin - New York NY

New York University - New York NY

A61K 3170

514 46

Agonists of the adenosine A. sub. 2 receptor promote the migration of endothelial cells, fibroblasts and epithelial cells. Thus, methods and pharmaceutical compositions useful for treating wounds and promoting wound healing comprise agents which cause stimulation of the adenosine A. sub. 2 receptor, preferably receptor agonists and adenosine uptake blockers. Preferred agonists include 2-phenylaminoadenosine, 2-para-2-carboxyethylphenyl-amino-5'N-ethylcarboxamidoadenosine, 5'N-ethylcarbox-amidoadenosine, 5'N-cyclopropyladenosine, 5'N-methyl-carboxamidoadenosine and PD-125944. Preferred uptake blockers include dipyridamole, nitrobenzylthio-inosine, dilazep and R75231.

6020321, Feb 1, 2000

Feb 3, 1999

9/243538

Bruce N. Cronstein - New York NY
Richard I. Levin - New York NY

New York University - New York NY

A61K 3170, C07H 19167

514 46

Agonists of the adenosine A. sub. 2 receptor promote the migration of endothelial cells, fibroblasts and epithelial cells. Thus, methods and pharmaceutical compositions useful for treating wounds and promoting wound healing comprise agents which cause stimulation of the adenosine A. sub. 2 receptor, preferably receptor agonists and adenosine uptake blockers. Preferred agonists include 2-phenylaminoadenosine, 2-para-2-carboxyethylphenyl-amino-5'N-ethylcarboxamidoadenosine, 5'N-ethylcarbox-amidoadenosine, 5'N-cyclo-propyladenosine, 5'N-methylcarboxamidoadenosine and PD-125944. Preferred uptake blockers include dipyridamole, nitrobenzylthio-inosine, dilazep and R75231.